A. Ruíz

1.3k total citations
39 papers, 887 citations indexed

About

A. Ruíz is a scholar working on Oncology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, A. Ruíz has authored 39 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Cancer Research and 11 papers in Reproductive Medicine. Recurrent topics in A. Ruíz's work include Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (10 papers) and Ovarian function and disorders (6 papers). A. Ruíz is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (10 papers) and Ovarian function and disorders (6 papers). A. Ruíz collaborates with scholars based in Spain, Canada and Brazil. A. Ruíz's co-authors include António Pellicer, Carlos Simón, J. Remohı́, Aňa Lluch, F. Miró, Mercedes Ruiz, Fernando Bonilla‐Musoles, Juan A. García-Velasco, A. Antón and Miguel Ángel Seguí and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

A. Ruíz

35 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Ruíz Spain	15	333	323	265	183	141	39	887
Michitaka Ohwada Japan	19	455 1.4×	203 0.6×	95 0.4×	128 0.7×	67 0.5×	86	1.0k
Jamal Rahaman United States	18	571 1.7×	163 0.5×	101 0.4×	230 1.3×	50 0.4×	52	1.3k
Victor Mak Canada	18	323 1.0×	80 0.2×	235 0.9×	80 0.4×	115 0.8×	35	943
Anne Perdrix France	15	436 1.3×	199 0.6×	369 1.4×	169 0.9×	72 0.5×	50	933
Jean Michel Bidart France	10	162 0.5×	166 0.5×	101 0.4×	83 0.5×	55 0.4×	12	960
Anita Chudecka-Głaz Poland	17	375 1.1×	232 0.7×	123 0.5×	155 0.8×	43 0.3×	85	863
R Rénaud France	18	132 0.4×	339 1.0×	251 0.9×	131 0.7×	109 0.8×	57	1.0k
Alice Bergamini Italy	17	690 2.1×	174 0.5×	344 1.3×	50 0.3×	153 1.1×	91	1.1k
Amiram Fishman Israel	13	273 0.8×	119 0.4×	107 0.4×	53 0.3×	62 0.4×	17	622
Catherine N. Correa United States	10	323 1.0×	235 0.7×	79 0.3×	83 0.5×	24 0.2×	17	712

Countries citing papers authored by A. Ruíz

Since Specialization

Citations

This map shows the geographic impact of A. Ruíz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ruíz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ruíz more than expected).

Fields of papers citing papers by A. Ruíz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ruíz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ruíz. The network helps show where A. Ruíz may publish in the future.

Co-authorship network of co-authors of A. Ruíz

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ruíz. A scholar is included among the top collaborators of A. Ruíz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ruíz. A. Ruíz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruíz, A., et al.. (2025). Palm plantations and grasslands represent a threat to the structure, diversity, and functional traits of dung beetles (Coleoptera: Scarabaeinae) in Orinoquia’s forests. Global Ecology and Conservation. 62. e03798–e03798.

Escudero, M.J., Eva Carrasco, Begoña Bermejo, et al.. (2019). Evolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III project. Clinical & Translational Oncology. 21(12). 1746–1753. 1 indexed citations

Templeton, Arnoud J., Álvaro Rodríguez-Lescure, A. Ruíz, et al.. (2018). Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy. Clinical & Translational Oncology. 20(12). 1548–1556. 10 indexed citations

Ruíz‐Borrego, Manuel, M. Martín Jiménez, A. Ruíz, et al.. (2017). Phase III evaluating the addition of fulvestrant (F) to anastrozol (A) as adjuvant therapy in postmenopausal women with hormone receptor positive HER2 negative (HR+/HER2-) early breast cancer (EBC): Results from the GEICAM/2006-10 study. Annals of Oncology. 28. v43–v43. 4 indexed citations

Coloma, Carmen Salvador, Pilar Sepúlveda, Laura Palomar, et al.. (2016). Anthracycline mediated cardiotoxicity: Detection of miRNA based early biomarkers for the prediction of myocardial injury. Hecatos study. Annals of Oncology. 27. vi90–vi90.

Alés‐Martínez, José E., A. Ruíz, José Ignacio Chacón, et al.. (2014). Preventive treatments for breast cancer: recent developments. Clinical & Translational Oncology. 17(4). 257–263. 8 indexed citations

Antón, A., A. Ruíz, Arrate Plazaola, et al.. (2010). Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study. Annals of Oncology. 22(1). 74–79. 27 indexed citations

Schneeweiß, Andreas, Frederik Marmé, A. Ruíz, et al.. (2010). A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer. Annals of Oncology. 22(3). 609–617. 17 indexed citations

Pacheco, Alberto, et al.. (2008). Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome. Human Reproduction. 23(3). 662–667. 24 indexed citations

10.

Antón, A., A. Ruíz, Miguel Ángel Seguí, et al.. (2008). Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study. Annals of Oncology. 20(3). 454–459. 10 indexed citations

11.

Martín, Miguel, Aňa Lluch, Miguel Ángel Seguí, et al.. (2006). Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. Annals of Oncology. 17(8). 1205–1212. 156 indexed citations

12.

Pérez-Manga, G., Manuel Constenla, A. Ruíz, et al.. (2004). Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer. British Journal of Cancer. 90(9). 1740–1746. 42 indexed citations

13.

Castel, Victoria, et al.. (2002). The role of surgery in stage IV neuroblastoma. Journal of Pediatric Surgery. 37(11). 1574–1578. 56 indexed citations

14.

Gil‐Salom, Manuel, J.L. Romero, Carmen Rubio, et al.. (2000). Intracytoplasmic sperm injection with cryopreserved testicular spermatozoa. Molecular and Cellular Endocrinology. 169(1-2). 15–19. 40 indexed citations

15.

Neuspiller, Fernando, et al.. (1998). The use of long- and short-acting forms of gonadotrophin-releasing hormone analogues in women undergoing oocyte donation. Human Reproduction. 13(5). 1148–1151. 11 indexed citations

16.

Remohı́, J., Antonio Gutiérrez, Fidel Cano, et al.. (1995). Long oestradiol replacement in an oocyte donation programme. Human Reproduction. 10(6). 1387–1391. 63 indexed citations

17.

Bolufer, Pascual, Elena Ricart, Aňa Lluch, et al.. (1992). Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis staging.. Journal of Clinical Oncology. 10(3). 438–446. 48 indexed citations

18.

López‐Ginés, Concha, Robert C. Callaghan, A. Ruíz, et al.. (1992). Cytogenetics, flow cytometry, cytophotometry and morphometry of 22 cases of primary breast carcinoma. Virchows Archiv B Cell Pathology Including Molecular Pathology. 61(1). 133–140. 7 indexed citations

19.

Pellicer, António, Carlos Simón, F. Miró, et al.. (1989). Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotrophin-releasing hormone analogues in different phases of the menstrual cycle. Human Reproduction. 4(3). 285–289. 58 indexed citations

20.

Pellicer, António, A. Ruíz, Carmen Ródenas Calatayud, et al.. (1989). Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins?. Human Reproduction. 4(5). 536–540. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact